Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Vanda Pharmaceuticals Inc. | 175,000 | reported | 20 Apr 2015 | tx 2+235,000 |
| OptiNose, Inc. | 5,364 | reported | 28 Jun 2019 | tx 7+180,676−2,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 Jun 2019 | GRANT_AWARD | OptiNose, Inc. | 2,768 | 5.64 USD | |
| 17 Apr 2019 | GRANT_AWARD | OptiNose, Inc. | 20,600 | 0.00 USD | deriv |
| 07 Mar 2019 | SALE | OptiNose, Inc. | 2,000 | 8.24 USD | |
| 28 Feb 2019 | GRANT_AWARD | OptiNose, Inc. | 82,500 | 0.00 USD | deriv |
| 31 Dec 2018 | GRANT_AWARD | OptiNose, Inc. | 611 | 5.42 USD | |
| 15 Aug 2018 | PURCHASE | OptiNose, Inc. | 2,000 | 12.69 USD | |
| 12 Oct 2017 | GRANT_AWARD | OptiNose, Inc. | 72,197 | 0.00 USD | deriv |
| 20 Apr 2015 | GRANT_AWARD | Vanda Pharmaceuticals Inc. | 60,000 | 0.00 USD | deriv |
| 20 Apr 2015 | GRANT_AWARD | Vanda Pharmaceuticals Inc. | 175,000 | 0.00 USD | deriv |